![]() |
市場調查報告書
商品編碼
1629618
腹膜透析市場按產品類型、應用、最終用戶和地區分類Peritoneal Dialysis Market, By Product Types, By Applications (Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis ), By End User, By Geography |
2024 年全球腹膜透析市場規模估計為 94.2 億美元,預計 2031 年將達到 139 億美元,2024 年至 2031 年的複合年成長率為 5.7%。
報告範圍 | 報告詳細資訊 | ||
---|---|---|---|
基準年 | 2023 | 2024 年的市場規模 | 94.2億美元 |
效能資料 | 2019-2023 | 預測期 | 2024 至 2031 年 |
預測期間 2024 年至 2031 年複合年成長率: | 5.70% | 2031 年價值預測 | 139億美元 |
全球腹膜透析市場的成長是由慢性腎臟病盛行率的上升和家庭血液透析機治療需求的不斷成長所推動的。腹膜透析是一種透過腹部的腹膜交換液體和電解質的腎臟替代療法。腹膜透析比傳統血液透析機有許多優勢,包括飲食限制更少、生活品質更高、液體管理更好。此外,開發中國家人口老化加劇、更容易患慢性病以及醫療成本上升可能會推動對腹膜透析的需求。然而,一些國家缺乏經驗豐富的腎臟病專家和報銷問題等因素可能會阻礙市場成長。
推動全球腹膜透析市場成長的關鍵因素包括導致末期腎病的糖尿病和高血壓盛行率不斷上升、已開發國家對家庭透析治療治療的優惠報銷政策、以及作為醫院血液透析機替代方案的慢性腎臟病治療的需求不斷成長。腹膜透析因其優於血液透析機而變得越來越受歡迎,包括改善生活品質、靈活性和減少飲食限制。然而,訓練有素的腎臟科專家短缺,特別是在開發中國家和低度開發地區,長期腹膜透析引起的腹膜炎風險也帶來了挑戰。此外,偏遠地區缺乏透析基礎設施也阻礙了市場的成長。腹膜透析設備、導管和提高透析效果和患者舒適度的解決方案的技術創新不斷增加,為市場擴張提供了機會。
本研究的主要特點
本報告對全球腹膜透析市場進行了詳細分析,並展示了預測期(2024-2031 年)的市場規模(十億美元)和年複合成長率(CAGR%),以 2023 年為基準年。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球腹膜透析市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行的分析。
研究中介紹的主要企業包括百特國際公司 (Baxter International Inc.)、費森尤斯醫療保健股份公司 (Fresenius Medical Care AG & Co. KGaA)、美敦力公司 (Medtronic plc)、B. Braun Melsungen AG. Dialife SA、Renal Solutions, Inc.、東麗株式會社 (Toray Industries, Inc.)、日本光電株式會社 (Nihon Kohden Corporation)、百特醫療集團 (Baxter Healthcare Corporation)、SWS 血液透析護理公司 (SWS Hemodialysis Care, Inc.) 和安斯泰來製藥公司 (Astellas Pharma Inc.)。
從本報告中獲得的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球腹膜透析市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球腹膜透析市場的各種策略矩陣來促進決策。
Global peritoneal dialysis market is estimated to be valued at USD 9.42 Bn in 2024 and is expected to reach USD 13.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 9.42 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 5.70% | 2031 Value Projection: | US$ 13.90 Bn |
Global peritoneal dialysis market growth is driven by rising prevalence of chronic kidney disease and growing demand for home hemodialysis treatment. Peritoneal dialysis is a kidney replacement therapy performed using fluid and electrolyte exchange through the peritoneal membrane in the abdomen. It offers various advantages over conventional hemodialysis such as fewer dietary restrictions, improved quality of life, and better fluid management. Moreover, growing geriatric population prone to chronic diseases and increasing healthcare expenditure in developing nations can boost demand for peritoneal dialysis procedures. However, factors such as lack of experienced nephrologists and reimbursement issues in some countries may hamper the market growth.
Key drivers propelling the global peritoneal dialysis market growth include growing prevalence of diabetes and hypertension leading to end-stage renal disease, favorable reimbursement policies for home dialysis therapies in developed nations, and increasing demand for chronic kidney disease treatment alternatives to hospital-based hemodialysis. Benefits of peritoneal dialysis over hemodialysis such as improved quality of life, flexibility, and less dietary restrictions boosts its adoption rates. However, shortage of trained nephrologists especially in developing and underdeveloped regions and risk of peritonitis with long-term peritoneal dialysis pose challenges. Moreover, lack of dialysis infrastructure in remote areas can also hamper the market growth. Ongoing innovations in peritoneal dialysis machines, catheters and solutions aimed at enhancing efficacy and patient comfort offer opportunities for market expansion.
Key Features of the Study
This report provides in-depth analysis of the global peritoneal dialysis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peritoneal dialysis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, B. Braun Melsungen AG, Nipro Corporation, Cook Medical, Asahi Kasei Medical Co., Ltd., Gambro (part of Fresenius), Dialife SA, Renal Solutions, Inc., Toray Industries, Inc., Nihon Kohden Corporation, Baxter Healthcare Corporation, SWS Hemodialysis Care, Inc., and Astellas Pharma Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global peritoneal dialysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peritoneal dialysis market